JAMIESON; Gene C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for JAMIESON; Gene C..The latest application filed is for "compositions and kits for the removal of irritating compounds from bodily surfaces".

Company Profile

3.5.8

JAMIESON; Gene C. - Boulder Creek CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions And Kits For The Removal Of Irritating Compounds From Bodily Surfaces App 20210205205 - ANGEL; Arturo J. ; et al.	2021-07-08
Compositions and kits for the removal of irritating compounds from bodily surfaces Grant 10,869,827 - Angel , et al. December 22, 2	2020-12-22
Compositions And Kits For The Removal Of Irritating Compounds From Bodily Surfaces App 20200085718 - ANGEL; Arturo J. ; et al.	2020-03-19
Compositions and kits for the removal of irritating compounds from bodily surfaces Grant 10,463,598 - Angel , et al. No	2019-11-05
Compositions and kits for the removal of irritating compounds from bodily surfaces Grant 9,549,893 - Angel , et al. January 24, 2	2017-01-24
Compositions And Kits For The Removal Of Irritating Compounds From Bodily Surfaces App 20150104498 - ANGEL; Arturo J. ; et al.	2015-04-16
Methods And Compositions For Administration Of Trpv1 Agonists App 20120309836 - Muhammad; Naweed ; et al.	2012-12-06
Methods And Compositions For Administration Of Trpv1 Agonists App 20110196043 - Muhammad; Naweed ; et al.	2011-08-11
Methods And Compositions For Administration Of Trpv1 Agonists App 20110184069 - MUHAMMAD; Naweed ; et al.	2011-07-28
Methods and compositions for administration of TRPV1 agonists Grant 7,943,166 - Muhammad , et al. May 17, 2	2011-05-17
Device for delivery of TRPV1 agonists App 20060204561 - Muhammad; Naweed ; et al.	2006-09-14
Methods and compositions for administration of TRPV1 agonists App 20050090557 - Muhammad, Naweed ; et al.	2005-04-28
Use of fullerenes in diagnostic and/or therapeutic agents Grant 5,688,486 - Watson , et al. November 18, 1	1997-11-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.